カテゴリ： GlobalData, イスラエル, 企業調査

InSightec Ltd：企業の製品パイプライン分析2018

◆英語タイトル：InSightec Ltd - Product Pipeline Analysis, 2018 Update
◆商品コード：DATA904C12181
◆発行会社（調査会社）：GlobalData
◆発行日：2018年12月
◆ページ数：37
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：イスラエル
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD1,500 ⇒換算￥222,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD2,250 ⇒換算￥333,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Insightec Ltd (InSightec), a subsidiary of Elbit Imaging Ltd, is a medical device company that develops and markets magnetic resonance imaging ultrasound based medical devices. The company offers products through divisions such as neurosurgery, urology, oncology and womens’ health. Its services include commercial development advisory, free professional services, free platform upgrade, onsite support, parts warranty, periodic maintenance, onsite clinical training, business support, customer services, remote technical support and software upgrades. InSightec’s products are used by physicians in medical facilities in the treatment of tumor. The company has operations in China, Israel, Japan and the UK. InSightec is headquartered in Tirat Carmel, Israel.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company InSightec Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
InSightec Ltd Company Overview 6
InSightec Ltd Company Snapshot 6
InSightec Ltd Pipeline Products and Ongoing Clinical Trials Overview 6
InSightec Ltd – Pipeline Analysis Overview 8
InSightec Ltd – Key Facts 8
InSightec Ltd – Major Products and Services 9
InSightec Ltd Pipeline Products by Development Stage 10
InSightec Ltd Ongoing Clinical Trials by Trial Status 12
InSightec Ltd Pipeline Products Overview 14
ExAblate – Brain Cancer 14
ExAblate – Brain Cancer Product Overview 14
ExAblate – Brain Cancer Clinical Trial 15
ExAblate – Breast Cancer 16
ExAblate – Breast Cancer Product Overview 16
ExAblate – Breast Cancer Clinical Trial 17
ExAblate – Liver Cancer 18
ExAblate – Liver Cancer Product Overview 18
ExAblate 2100 Prostate System 19
ExAblate 2100 Prostate System Product Overview 19
ExAblate 2100 Prostate System Clinical Trial 20
ExAblate Neuro 21
ExAblate Neuro Product Overview 21
ExAblate Neuro Clinical Trial 22
Exablate Neuro – Alzheimer’s Disease 24
Exablate Neuro – Alzheimer’s Disease Product Overview 24
Exablate Neuro – Alzheimer’s Disease Clinical Trial 25
InSightec Ltd – Key Competitors 26
InSightec Ltd – Key Employees 27
InSightec Ltd – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
InSightec Ltd, Recent Developments 29
Jul 03, 2018: INSIGHTEC”s MR-Guided Focused Ultrasound Treatment for Essential Tremor Now Covered by Medicare in Six Additional States 29
Jun 20, 2018: Insightec””s MRgFUS Earns Positive Nice Guidance For Treatment Of Essential Tremor 29
Jun 04, 2018: INSIGHTEC”s MR-Guided Focused Ultrasound Treatment for Essential Tremor Now Covered by Medicare 30
May 14, 2018: INSIGHTEC Submits Pre-market Approval to Japanese PMDA of MR-guided Focused Ultrasound Surgery for Treatment of Parkinson”s Disease 30
May 02, 2018: Focused Ultrasound Extends Its Focus: INSIGHTEC Initiates Parkinson”s Disease Study With First Patient Treated With Incisionless Brain Surgery 30
Feb 20, 2018: Israel Ministry of Health Includes INSIGHTEC’s Focused Ultrasound Treatment for Medication-Refractory Essential Tremor as Part of Covered Health Services 31
Nov 29, 2017: The Taiwanese Food and Drug Administration Approved Exablate Neuro for the Treatment of Essential Tremor 31
Oct 27, 2017: Insightec’s Exablate Neuro Named Best Medical Technology At Esteemed Prix Galien Awards 2017 32
Oct 25, 2017: INSIGHTEC Receives FDA Approval to Initiate Pivotal Study of Exablate Neuro for the Treatment of Patients with Parkinson’s Disease 32
Aug 23, 2017: The First MR-Guided Focused Ultrasound Treatment for Essential Tremor Was Performed in Taiwan 33
Appendix 34
Methodology 34
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
InSightec Ltd Pipeline Products and Ongoing Clinical Trials Overview 6
InSightec Ltd Pipeline Products by Equipment Type 7
InSightec Ltd Pipeline Products by Indication 7
InSightec Ltd Ongoing Clinical Trials by Trial Status 7
InSightec Ltd, Key Facts 8
InSightec Ltd, Major Products and Services 9
InSightec Ltd Number of Pipeline Products by Development Stage 10
InSightec Ltd Pipeline Products Summary by Development Stage 11
InSightec Ltd Ongoing Clinical Trials by Trial Status 12
InSightec Ltd Ongoing Clinical Trials Summary 13
ExAblate - Brain Cancer - Product Status 14
ExAblate - Brain Cancer - Product Description 14
ExAblate - Brain Cancer - A Study to Evaluate the Safety and Feasibility of Blood-brain Barrier Disruption Using Transcranial MRI-guided Focused Ultrasound with Intravenous Ultrasound Contrast Agents in the Treatment of Brain Tumours with Doxorubicin 15
ExAblate - Brain Cancer - A Study to Evaluate the Safety and Feasibility of Transcranial MRI-guided Focused Ultrasound Surgery in the Treatment of Brain Tumors 15
ExAblate - Brain Cancer - A Study to Evaluate the Safety and Feasibility of Transcranial MRI-guided Focused Ultrasound Surgery in the Treatment of Brain Tumors 15
ExAblate - Breast Cancer - Product Status 16
ExAblate - Breast Cancer - Product Description 16
ExAblate - Breast Cancer - A Clinical Study to Evaluate the Safety and Effectiveness of MR Guided Focused Ultrasound Surgery in the Treatment of Early Breast Carcinomas 17
ExAblate - Liver Cancer - Product Status 18
ExAblate - Liver Cancer - Product Description 18
ExAblate 2100 Prostate System - Product Status 19
ExAblate 2100 Prostate System - Product Description 19
ExAblate 2100 Prostate System - Focal MR-guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions 20
ExAblate 2100 Prostate System - Focal MR-guided Focused Ultrasound Treatment of Localized Low-intermediate Risk Prostate Cancer: Feasibility Study 20
ExAblate Neuro - Product Status 21
ExAblate Neuro - Product Description 21
ExAblate Neuro - A Feasibility Study to Evaluate Safety and Initial Effectiveness of MR-Guided Focused Ultrasound Ablation Therapy in the Treatment of Subcortical Lesional Epilepsy 22
ExAblate Neuro - A Pivotal Clinical Trial of the Management of the Medically-refractory Dyskinesia Symptoms or Motor Fluctuations of Advanced Idiopathic Parkinson's Disease with Unilateral Lesioning of the Globus Pallidum Using the ExAblate Neuro System 22
ExAblate Neuro - A Study to Evaluate the Effectiveness and Safety of Exablate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects 22
ExAblate Neuro - Assessment of Safety and Feasibility of ExAblate Blood-brain Barrier Disruption for the Treatment of High Grade Glioma in Patients Undergoing Standard Chemotherapy 22
ExAblate Neuro - Mapping Functional Networks of Brain Activity Using EEG in Patients with Essential Tremor or Parkinson Disease Before and after MR-guided Focused Ultrasound Thalamotomy for Tremor 23
Exablate Neuro - Alzheimer’s Disease - Product Status 24
Exablate Neuro - Alzheimer’s Disease - Product Description 24
Exablate Neuro - Alzheimer’s Disease - A Phase IIa Study to Evaluate the Safety and Efficacy of Blood-Brain Barrier (BBB) Opening Using Transcranial MR-guided Focused Ultrasound in Patients with Alzheimer's Disease 25
Exablate Neuro - Alzheimer’s Disease - Assessment of Safety and Efficacy of ExAblate Blood-brain Barrier Disruption for the Treatment of Patients with Probable Alzheimer's Disease 25
InSightec Ltd, Key Employees 27
InSightec Ltd, Other Locations 28
Glossary 36

List of Figures
InSightec Ltd Pipeline Products by Equipment Type 7
InSightec Ltd Pipeline Products by Development Stage 10
InSightec Ltd Ongoing Clinical Trials by Trial Status 12

★海外企業調査レポート[InSightec Ltd：企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Enel Green Power SpA：企業の戦略的SWOT分析
    Enel Green Power SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Sterling Bank Plc：企業の戦略・SWOT・財務情報
    Sterling Bank Plc - Strategy, SWOT and Corporate Finance Report Summary Sterling Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • MTY Food Group Inc.：戦略・SWOT・企業財務分析
    MTY Food Group Inc. - Strategy, SWOT and Corporate Finance Report Summary MTY Food Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Brembo SpA：企業の戦略・SWOT・財務情報
    Brembo SpA - Strategy, SWOT and Corporate Finance Report Summary Brembo SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • The Boeing Co (BA)：企業の財務・戦略的SWOT分析
    The Boeing Co (BA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • China Sunshine Paper Holdings Company Limited：企業の戦略・SWOT・財務情報
    China Sunshine Paper Holdings Company Limited - Strategy, SWOT and Corporate Finance Report Summary China Sunshine Paper Holdings Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • ASUSTeK Computer Inc. (2357)：企業の財務・戦略的SWOT分析
    ASUSTeK Computer Inc. (2357) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Yanlord Land Group Ltd：企業の戦略・SWOT・財務分析
    Yanlord Land Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Yanlord Land Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Seagen Inc (SGEN)：企業の財務・戦略的SWOT分析
    Seagen Inc (SGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Yifan Pharmaceutical Co.,Ltd：企業の戦略・SWOT・財務情報
    Yifan Pharmaceutical Co.,Ltd - Strategy, SWOT and Corporate Finance Report Summary Yifan Pharmaceutical Co.,Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • bet-at-home.com AG (ACX)：企業の財務・戦略的SWOT分析
    bet-at-home.com AG (ACX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Wyndham Destinations, Inc.：企業の戦略・SWOT・財務情報
    Wyndham Destinations, Inc. - Strategy, SWOT and Corporate Finance Report Summary Wyndham Destinations, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Feldan Bio Inc-製薬・医療分野：企業M&A・提携分析
    Summary Feldan Bio Inc (Feldan) is a biotechnology company. It discovers, develops, manufactures and markets research therapeutic and industrial protein products. The company offers cell therapy products, genome editing products and research products. Its genome editing product includes recombinant …
  • China Aerospace Science and Technology Corporation：企業の戦略・SWOT・財務情報
    China Aerospace Science and Technology Corporation - Strategy, SWOT and Corporate Finance Report Summary China Aerospace Science and Technology Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • Riemser Pharma GmbH：製薬・医療：M&Aディール及び事業提携情報
    Summary Riemser Pharma GmbH (Riemser), formerly Riemser Arzneimittel AG is a distributor of lifecycle management products. The company offers analgesics products, cardiovascular products, over-the-counter medicines, prescription drugs and dental products. It provides medical products for the treatme …
  • Mediolanum farmaceutici SpA-製薬・医療分野：企業M&A・提携分析
    Summary Mediolanum farmaceutici SpA (Mediolanum) is a healthcare solution provider that discovers, develops and markets pharmaceuticals products and prescription drugs. The company offers products in therapeutic areas which include neuropsychiatric, osteoarticular, antibiotic, pneumoallergological, …
  • Tokyo Seimitsu Co., Ltd. (7729)：企業の財務・戦略的SWOT分析
    Tokyo Seimitsu Co., Ltd. (7729) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Advantest Corporation：企業の戦略・SWOT・財務情報
    Advantest Corporation - Strategy, SWOT and Corporate Finance Report Summary Advantest Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Nisshinbo Holdings Inc (3105)：企業の財務・戦略的SWOT分析
    Nisshinbo Holdings Inc (3105) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Cevec Pharmaceuticals GmbH：企業のM&A・事業提携・投資動向
    Cevec Pharmaceuticals GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cevec Pharmaceuticals GmbH Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆